Joel Rothman
Corporate Officer/Principal at EQUILLIUM, INC.
Net worth: 105 252 $ as of 29/04/2024
Profile
Joel M.
Rothman is currently the Chief Development Officer at Equillium, Inc. He previously worked as the Director-Regional Operations at ICON Clinical Research, Inc. from 1998 to 2004, Vice President at Cytokinetics, Inc. from 2017 to 2018, Vice President-Development Operations at Jazz Pharmaceuticals, Inc., and Vice President at Raptor Pharmaceuticals, Inc. from 2015 to 2017.
Rothman received his undergraduate degree from Albright College and his graduate degree from Massachusetts Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EQUILLIUM, INC.
0.16% | 01/01/2024 | 58,150 ( 0.16% ) | 105 252 $ | 29/04/2024 |
Joel Rothman active positions
| Companies | Position | Start |
|---|---|---|
| EQUILLIUM, INC. | Corporate Officer/Principal | 31/12/2020 |
Former positions of Joel Rothman
| Companies | Position | End |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 31/08/2018 |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Corporate Officer/Principal | 31/12/2016 |
ICON Clinical Research, Inc.
 ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Corporate Officer/Principal | 30/06/2004 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Training of Joel Rothman
| Albright College | Undergraduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| EQUILLIUM, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
ICON Clinical Research, Inc.
ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Commercial Services |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Health Technology |
- Stock Market
- Insiders
- Joel Rothman
